Enesi Pharma are attending the World Vaccine Congress, Washington 3-5 April 2018.
David Hipkiss, CEO, will be presenting our latest developments in the Viral Vectors & Novel Platforms Technology Showcase entitled ImplaVaxTM , Unique needle free solid dose vaccine platform delivering enhanced immunogenicity with ultimate convenience and no cold chain at 10.25am on Wednesday, in Ballroom level Renaissance Ballroom B
Enesi Pharma also have a presence at Booth 116.